your search results
Simply choose your interests by category and year. You can reduce your result list by deactivating categories you are not interested in.
Safety Meets Accessibility: Creating the Ideal Packaging for On-The-Go Dosage Forms
Our innovative stick packs combine child-resistant safety with senior-friendly accessibility. Engineered for modern patient needs, they enable precise, fast and water-free medication intake while preventing accidental openings. Read how our new laser-cut design meets international safety standards while ensuring convenience without compromise – article published in Contract Pharma.
CPHI 2025
HERMES PHARMA is exhibiting at the upcoming CPHI 2025 Worldwide from October 28 – 30 in Frankfurt, Germany.
Effervescent Evolution: New Technologies and Method Revitalize a Time-Tested Dosage Form
We have introduced a new advancement in effervescent tablet manufacturing. The patented manufacturing method not only enhances production efficiency, but also delivers excellent palatability while reducing environmental impact. The secured patent protection underscores HERMES PHARMA’s commitment to refining pharmaceutical delivery solutions while ensuring product exclusivity. Article published by Tablets & Capsules.
HERMES PHARMA Receives Recognition for Research Excellence from German Government
HERMES PHARMA has been awarded the BSFZ seal from the German Certification Office for Research Allowance. This recognition underscores our contributions to innovation in pharmaceutical manufacturing as well as our commitment to advancing healthcare solutions that benefit all – industry partners, patients and consumers.
HERMES PHARMA product portfolio
Interested in our newly developed products? You can now download the 2025 version of our Product & Development Portfolio. The document presents a choice of products we currently have available for you to in-license, plus our newly developed clean and natural formulations. (Please note, download requires registration of contact details).
Reducing Risk, Speeding Development — a CDMO Model Including GCP-Sponsorship to Better Meet the Needs of Pharma Companies
Pharmaceutical companies are under mounting pressure to develop more user-friendly products. Faced with fierce competition, they’re also demanding more CDMO support than ever. How does a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate go-to-market? Read this Q&A with Drug Development & Delivery.